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REPAIR OF THORACIC AORTIC ANEURYSMS 
Conventional repair of aneurysms of the descending thoracic aorta entails 
thoracotomy and graft interposition. For elderly patients and those with 
previous operations, obesity, respiratory insufficiency, or other comorbidi- 
ties, such a procedure ntails significant mortality and morbidity. Trans- 
luminal stent-graft placement offers an alternative approach with poten- 
tially less morbidity and quicker recovery; however, the effectiveness and 
durability of stentlgrafts remain uncertain. Methods: Since July 1992, 
thoracic aortic stent-grafts have been placed in 44 patients with a variety of 
pathologic onditions. Each graft was individually constructed from self- 
expanding, stainless-steel Z stents covered with a woven Dacron polyester 
fabric graft. Graft dimensions were determined from spiral computed 
tomographic scans. All implants were performed in the operating theater 
under fluoroscopic and transesophageal echocardiographic guidance. 
Follow-up was by computed tomography and contrast angiography in all 
cases. Patient data: There were 36 men and 8 women. Mean age was 66 years 
(range 35 to 88 years). Mean aneurysmal diameter was 6.3 cm (range 4.0 to 
9.4 cm). Etiologies included 23 degenerative aneurysms, four posttraumatic 
aneurysms, four pseudoaneurysms, and one chronic aortic dissection. 
Results: There were three early deaths (<30 days) and two late deaths. One 
early death resulted from graft failure. There were two instances of 
paraparesis or paraplegia, with one associated early death. A single stent 
was deployed in 27 patients, two stents were required in 14 patients, and 
three stents were required in three patients. In 23 patients, vascular access 
was attained through the femoral artery; abdominal aortic access, either 
native or graft, was necessary in the remaining 21 patients. Twelve grafts 
were placed in conjunction with open abdominal aortic surgical procedures. 
Mean follow-up (98% complete) was 12.6 months (range 1 to 34 months). 
One late death occurred from aneurysmal expansion and rupture in a 
patient with a persistent midgraft leak. The second late death may have 
resulted from aneurysmal rupture. Immediate thrombosis was achieved in 
36 patients, and late thrombosis was achieved in three others. Failure to 
achieve complete aneurysmal thrombosis occurred in five patients, how- 
ever, and one individual (previously noted) died of aneurysmal expansion 
and rupture; the remaining four are being carefully monitored. Only one 
patient has required conversion of the stent to an open procedure; a
contained rupture of the false lumen of a chronic dissection eventually 
necessitated total descending thoracic aortic exclusion. Conclusions: These 
early results support he hypothesis that endovascular stent-graft place- 
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ment may be a safe and durable treatment for selected patients with 
aneurysmal disease of the descending thoracic aorta. Large introducer size 
(26F outer diameter) and relatively limited angulation capability, as well as 
imprecise deployment echniques, currently limit its applicability. Distal 
embolization and stent migration have not been observed. Failure to 
achieve complete aneurysmal thrombosis may allow continued aneurysmal 
expansion and rupture. Further follow-up is clearly necessary to evaluate 
the true long-term effectiveness of this procedure. (J Thorac Cardiovasc 
Surg 1996;111:1054-62) 
p atients with aneurysms of the thoracic aorta con- 
tinue to present important clinical problems. There 
appears to be an increase in the absolute number of 
aneurysms, which may reflect he increased life expect- 
ancy of the population or perhaps may reflect im- 
proved diagnostic capabilities. Since the first reports of 
homograft repair of thoracic aortic aneurysms by Swan 
and coworkers 1 in 1950 and DeBakey and Cooley 2in 
1953, aneurysmal repair has become awidely accepted 
treatment modality. Nevertheless, these procedures 
are still associated with significant morbidity, chiefly 
related to major thoracotomy, use of cardiopulmonary 
bypass with its attendant antic0agulation i many 
cases, and postoperative complications including 
bleeding, paraplegia, stroke, renal insufficiency, and 
the necessity for prolonged ventilatory support. Since 
July 1992, we have experimented with an endovascular 
stent-graft repair technique for descending thoracic 
aortic aneurysms in an effort to minimize such mor- 
bidities. 
The incidence of thoracic aortic aneurysms is 
estimated to be approximately 6 cases/100,000 per- 
son-years) The afflicted population isusually elderly 
and predominantly male. Frequent comorbidities 
include hypertension, coronary artery disease, ob- 
structive pulmonary disease, and congestive heart 
failure, all of which have significant impact on recovery 
from operative repair. Concomitant abdominal aortic 
aneurysms have been estimated to occur in 10% to 
20% of these patients. Although the natural history of 
patients with thoracic aortic aneurysms i not so well 
defined as that of patients with abdominal aortic 
aneurysms, Pressler and McNamara 4 reported the 
outcome in 22 patients treated medically: 40% died of 
progressive aneurysmal dilatation and rupture and 
32% died of other cardiovascular disease. The actu- 
arial 1- and 5-year survivals for patients not oper- 
ated on have been estimated to be 60% and 20%, 
respectively.3, 4 
Most aneurysms of the thoracic aorta are ath- 
erosclerotic or degenerative in etiology, Other 
causes include mycotic aneurysms, posttranmatic false 
aneurysms, and aneurysms of the ductus diverticulum. 
Recent experience has allowed some understanding of 
the evolution from aortic intramural hematomas and 
giant penetrating ulcers to the formation of thoracic 
aortic aneurysms. The role of hypertension is para- 
mount, contributing to the increased wall tension as 
well as causing degenerative changes in the medial cell 
layers. Increased size also causes an increase in wall 
tension, with further dilatation and eventual rupture. 
The traditional therapy for patients with thoracic 
aortic aneurysms i surgical repair. Although no pre- 
cise predictive criteria exist, most surgeons recom- 
mend repair of any symptomatic aneurysm or any 
aneurysm whose dimension exceeds one and one 
half to two times the transverse dimension of an 
adjacent normal aortic segment, providing the pa- 
tient is a reasonable candidate for the operation. 
Although there have been significant advances in 
the intraoperative and postoperative management 
of these elderly and frequently debilitated patients, 
operative mortality ranges from 5% to 20% in large 
series, s-7 and postoperative r nal and pulmonary 
insufficiency frequently results in prolonged hospital 
stays. 
Transluminally placed endovascular stent-grafts 
are an attractive alternative that may potentially 
reduce operative risk and perioperative morbidity. 
The success of the first endovascular repairs of 
abdominal aortic aneurysms s prompted our investi- 
gation into the feasibility of thoracic aortic aneurys- 
real repairs with transluminally placed endovascular 
stent-grafts. This report expands on our initial ex- 
perience with 13 patients 9 to our current experience 
of 44 patients operated on during a 34-month pe- 
riod, documents the mean follow-up of 12.6 months 
(range 1 to 34 months), and, perhaps most impor- 
tantly, allows some recommendations from our ad- 
mittedly steep learning curve. 
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Table I. Imaging protocol 
Chest Spiral 
radiography* CT Arteriography 
Before procedure x x x 
During procedure x x 
After procedure x x x 
2 mo after procedure x 
6 mo after procedure x x x 
1 yr after procedure x x x 
2 yr after procedure x x 
and annually thereafter 
CT, Computed tomography. 
*Posteroanterior and lateral chest radiographs. 
Fig. 1. Dacron polyester fabric graft covers a series of 
self-expanding Z stents. 
Methods 
Between July 1992 and May 1995, under an investiga- 
tional protocol approved by the Institutional Review 
Board of the Stanford University Medical Center, 44 
patients underwent transluminal endovascular stent-graft 
repair of thoracic aortic aneurysms. Informed consent was 
obtained from every patient before operation, and all 
patients were monitored after operation according to an 
approved imaging protocol (Table I). All procedureS were 
performed in the operating theater with the patient under 
general anesthesia, with monitoring by a portable digital 
radiographic G-arm image intensifier, transesophageal 
echocardiography, and invasive radial and pulmonary 
artery monitoring. Intraoperative angiography was per- 
formed in all cases, initially to localize the aneurysm and 
subsequently to confirm exclusion of the aneurysm after 
stent-graft deployment. Patients were positioned and 
draped sterilely for a lateral thoracotomy, a double-lumen 
endotracheal tube was inserted in most cases, and cardio- 
pulmonary bypass tandby was available for every case. 
Endovascular prosthesis. The endovascular stent-graft 
was individually constructed for each patient and was gas 
sterilized before use. In general, the stent-graft was over- 
sized by 2 to 3 mm to allow a continued radial expansile 
force and an effective friction seal. A stainless-steel en- 
doskeleton was constructed with a series of self-expanding 
Z-shaped stents "box-carred" together. A standard Cooley 
VERI-SOFT woven Dacron polyester fabric graft (Mea- 
dox Medicals, Inc., Oakland, N.J.) with its crimps ironed 
out was attached to the stent by a series of 5-0 interrupted 
polypropylene sutures (Fig. 1). The diameter and length 
of the stent-graft were d termined for each patient from 
measurements obtained from a preoperative spiral com- 
puted tomographic scan. The device was then radially 
compressed and loaded into a 26F (outer diameter) 
Teflon (polytetrafluoroethylene) sh ath. 
Endovascular procedure. With the patient under gen- 
eral anesthesia, the femoral artery, iliac artery, or abdom- 
inal aorta was surgically exposed. After precise localiza- 
tion of the aneurysmal neck by means of intraoperative 
angiography and transesophageal echocardiography, the 
26F (outer diameter) Teflon sheath with an indwelling 
obturator-dilator was introduced into the aortic arch over 
a superstiff 0.038 inch guide wire. After it traversed the 
aneurysm the obiurator was removed, leaving the sheath 
proximal to the proximal aneurysmal neck, and the stent- 
graft was loaded from its cartridge and advanced into the 
sheath under fluoroscopic guidance. 
Just before deployment, mean systemic arterial pres- 
sure was lowered to approximately 50 mm Hg with 
intravenous vasodilators and/3-blockers in an attempt to 
minimize distal migration of the graft during deployment. 
After final positioning, stent-graft deployment was accom- 
plished by rapidly withdrawing the sheath from around the 
self-expanding stent-graft. Completion angiography was 
then performed to confirm proper positioning, and addi- 
tional stent-grafts were placed proximally or distally as 
necessary to ensure aneurysmal exclusion. The sheath was 
then removed, the artery was repaired, and the patient 
was returned to the intensive care unit. Occasionally, a 
large (25 mm) angioplasty balloon was used to improve 
stent position or expansion. Total elimination of contrast 
enhancement of the aneurysmal sac (Fig. 2) was the 
desired objective in all cases. 
Patient population. These 44 patients had a heteroge- 
nous mix of pathologies and risk factors. During the same 
interval, 60 patients had conventional open repair of 
descending thoracic aortic aneurysms or dissections. In 
our early experience, the first four patients were all 
deemed surgical candidates. Soon thereafter, patients 
considered not to be operative candidates for a variety of 
pulmonary, cardiac, or other problems (Table II) were 
enrolled in this clinical experiment. There were 36 men 
and eight women. Mean age was 66 years (range 35 to 88 
years), and mean aneurysmal diameter was 6.3 cm (range 
4.0 to 9.4 cm). Etiologies included atherosclerosis in 24 
patients, intramural hematoma or penetrating ulcer in 
eight, chronic pOsttraumatic origin in four, pseudoaneu- 
rysm in four, ductus diverticular aneurysm in four, and 
chronic aortic digsection in one. The mean stent-graft 
diameter was 3.5 cm (range 2.4 to 4.5 cm), and the mean 
length of the device was 10.2 cm (range 5.0 to 18.0 cm). 
The femoral artery was the most common site for 
insertion; it was used in 21 patients. Twelve patients 
underwent concomitant abdominal aortic aneurysm repair 
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Fig. 2. A, Angiogram demonstrating aneurysm of the ductus diverticulum in a 77-year-old man. B, 
Computed tomographic scan of same patient, with aneurysm noted on underside of arch. C, After 
stent-graft deployment, the aneurysm no longer fills with contrast medium. D, Contrast-enhanced 
computed tomographic scan after stent-graft deployment confirms absence of aneurysm filling. 
with stent-graft insertion through a 10 mm side limb. A 
failed femoral artery cannulation prompted a retroperito- 
neal approach to the aorta in five patients, to a previous 
aortic graft in two patients, and to the iliac artery in two 
patients (Table III). As with any atherosclerotic patient 
population, other medical problems were frequently en- 
countered (Table IV): hypertension was present in 36, 
diabetes mellitus in eight, renal insufficiency in six, and 
congestive heart failure in nine. Thirty-three patients were 
or had been smokers, and chronic obstructive pulmonary 
disease was present in 22. Twelve had undergone previous 
cardiac operations, and 16 had a history of one or more 
previous aortic aneurysmal repairs. Twenty-two patients 
were considered to be reasonable operative candidates. 
The remaining 22 patients (50%) were deemed ineligible 
for a conventional thoracotomy approach; 16 on the basis 
of severe chronic obstructive pulmonary disease (forced 
expiratory volume in 1 second <700 ml), with or without 
accompanying coronary artery disease, congestive heart 
failure, renal insufficiency, and advanced age or chronic 
debility; three because of multiple previous thoracoto- 
mies, including two with a previous attempt at aneurysmal 
repair that had been aborted; and three additional pa- 
tients because of obesity, history of prolonged respiratory 
insufficiency, severe congestive heart failure, renal insuf- 
ficiency, severe coronary artery disease, or a combination 
of these factors (Table III). 
Results 
Stent deployment was technically successful in all 
cases, although multiple stents were required in 16 
patients (36%). Complete aneurysmal thrombosis 
was achieved immediately in 36 patients (81%). 
There were three deaths in the perioperative period. 
The first death occurred on postoperative day 27, 
after successful graft deployment, as a result of 
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Table II. Patient characteristics of nonoperative 
candidates 
Condition No. % 
COPD with or without CAD, CHF, 16 36 
renal insufficiency 
Multiple previous thoracotomies 3 7 
Previous ventilatory dependency, 3 7 
CHF, CAD, renal insufficiency 
TOTAL 22 50 
COPD, Chronic obstructive pulmonary disease; CAD, coronary artery 
disease; CHF, congestive heart failure. 
Table IV. Patient characteristics 
No.* %* 
History of tobacco use 33 75 
Hypertension 36 82 
COPD 22 50 
Diabetes mellitus 8 18 
Renal insufficiency 6 14 
COPD, Chronic obstructive pulmonary disease. 
*Number of patients does not add to 44 and percentages donot add to 100 
because, as with most aneurysm populations, these patients harbored 
multiple cardiovascular risk factors. 
Table III. Arterial access 
NO. % ~ 
Femoral artery 23 52 
Retroperitoneal pproach? 9 20 
Iliac artery 2 5 
Aorta 5 11 
Aortic graft 2 5 
Concomitant abdominal aortic 12 27 
aneurysm repairs 
*Percentages donot add to 100 because of rounding. 
tFailed femoral approach necessitated retroperitoneal approach in nine 
patients. 
:~Twelve patients underwent thoracic stent-graft placement concomitantly 
with abdominal aortic aneurysm repair through a 10 mm side limb. 
progressive r nal dysfunction and multisystem organ 
failure in an elderly (84-year-old) Asian man. The 
second eath occurred on postoperative day 31 after 
combined rerepair of a suprarenal aneurysm and 
thoracic stent-graft placement. This patient had a 
postoperative coagulopathy and ultimately died of 
renal and respiratory insufficiency and fungal septi- 
cemia. The third operative death occurred on the 
first postoperative day, after disruption of a previ- 
ously placed aortoiliac graft during sheath advance- 
ment. Emergency receliotomy with concomitant 
thoracic stent-graft placement resulted in a hemor- 
rhagic diathesis, with subsequent inability to main- 
tain adequate ventilation. Of note, none of these 
three patients were considered candidates for post- 
operative day conventional aneurysmal repair. 
There were two early instances of paraplegia. The 
first occurred in a white woman whose procedure 
was not performed according to protocol; no cardio- 
pulmonary bypass was on standby. Stent-graft de- 
ployment resulted in transient aortic occlusion, and 
distal aortic hypotension persisted for longer than 
60 minutes. Renal and hepatic insufficiency gradu- 
ally resolved in the perioperative period, and the 
neurologic deficit gradually improved. This patient 
subsequently became unavailable for follow-up. A 
second instance of paraplegia occurred in the same 
patient described as the second operative death. After 
rerepair of a suprarenal neurysm and deployment of
a thoracic stent-graft 12.5 cm in length, this white man 
was noted to be paraplegic. Whether distal emboliza- 
tion or intercostal rtery interruption was responsible 
for this spinal cord injury remains unknown. 
Difficulties related to imprecise graft deployment 
in juxtaposition to the left subclavian artery oc- 
curred in five patients. In one patient, thrombosis of 
the proximal subclavian artery developed periopera- 
tively after partial coverage of the subclavian ostium 
with the stent-graft, but this patient has remained 
free of symptoms for 7 months. One patient re- 
quired subclavian-to-carotid transposition for symp- 
tomatic subclavian occlusion 3 days after stent-graft 
placement. Another patient had a separate subcla- 
vian artery ostial stent placed to relieve impinge- 
ment by the aortic stent-graft. Two patients under- 
went subclavian-to-carotid ransposition procedures 
during the same operation but before stent-graft de- 
ployment, o create a more adequate proximal neck. 
Subintimal aortic dissections were created in two 
patients during stent-graft placement. One was cov- 
ered by a more proximally placed stent-graft. The 
second patient has been stable for longer than 4 
months, and follow-up 6-month computed tomo- 
graphic scan is pending. 
Another patient with a chronic type A dissection 
extending distally to the aortic bifurcation had a 
stent-graft placed for management of a contained 
rupture of the false lumen. Although this was suc- 
cessful, the patient required subsequent descending 
aortic exclusion 3 months after stent-grafting for 
continued thoracic pain. 
As previously noted, immediate aneurysmal ex- 
clusion was noted in 36 patients. Twenty-seven of 
these patients required only a single stent-graft, 
seven required two stent-grafts, and two required 
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three stent-grafts. Late aneurysmal thrombosis was 
attained in an additional three patients with coiling 
in one patient and an additional stent-graft in two 
patients, for an overall aneurysmal thrombosis rate 
of 88% (39/44). 
There were two late deaths. The first occurred 31/2 
months after operation from aneurysmal rupture 
into the patient's esophagus. This patient was known 
to have had an early failure of aneurysmal throm- 
bosis as the result of a midgraft leak and was 
scheduled for early return for further treatment. 
Unfortunately, a small-bowel obstruction unrelated 
to his stent-graft procedure developed, and the 
patient was hospitalized atanother institution for an 
extended period. During that hospitalization, aortic 
expansion was noted on a plain chest roentgeno- 
gram but was not further evaluated. Exsanguinating 
hemorrhage developed after subsequent aneurysmal 
expansion at its distal extent and erosion into the 
esophagus. This case emphasizes the importance of 
complete aneurysmal exclusion. A second patient 
died suddenly 12 months after stent-graft place- 
ment, presumably of an aneurysm-related hemor- 
rhage; complete aneurysmal exclusion had been 
noted before discharge. Actuarial survival at 35 
months was 82% (Fig. 3). 
All other patients (n = 37) are alive and well at 
last follow-up, a mean of 12.6 months after stent 
grafting. There have been no documented instances 
of late graft thrombosis, migration, infection, or 
embolization. In 15 patients followed up for longer 
than 1 year, one aneurysm continues to be incom- 
pletely thrombosed, nine aneurysmal sacs are un- 
changed in dimension, and five aneurysms have 
decreased in size. One patient acquired a new 
proximal leak 35 months after the initial stent-graft 
procedure. Percutaneous management with radio- 
graphic embolization has eliminated that leak. All 
survivors remain pain free. 
Discussion 
Endovascular aneurysmal repair has recently 
been popularized as a treatment ofabdominal ortic 
aneurysms and other peripheral arterial aneurysms. 
There appear to be two major prerequisites for such 
repair, vascular access of sufficient size and limited 
tortuosity and local anatomic suitability. Specifically, 
suitability entails a relatively straight segment of the 
aorta and the absence of nearby important side 
branches. Although curved segments of the distal 
aortic arch were able to be successfully grafted in 













Patients at Risk: 
40 31 27 25 20 15 10 9 6 4 1 1 
5 10 15 20 25 30 35 
Fig. 3. Actuarial survival after aortic stent-graft place- 
ment. Horizontal axis, survival in months; vertical axis, 
percent survival. 
most of the difficulties with maldeployments and 
aortic dissections. Proximity of the subclavian artery 
compromising an adequate proximal neck also 
caused problems, necessitating operative correction 
in four patients. Later in our experience, catheter 
access was first gained through the brachial artery if 
graft deployment was planned in close proximity to 
the left subclavian artery, with a guide wire travers- 
ing the subclavian artery into the aorta. This allowed 
subsequent s ent placement to maintain subclavian 
patency. There were no instances of grafts compro- 
mising the celiac axis or superior mesenteric artery, 
nor were there any instances of paraplegia ttribut- 
able solely to occlusion of patent intercostal rteries. 
If the expected graft location was sufficiently close to 
an intercostal artery thought o be important for 
distal spinal cord blood supply, a segment of uncov- 
ered stent was attached istally to anchor the pros- 
thesis, thus not compromising patent critical inter- 
costal flow. Because the exact etiology of paraplegia 
after operative repair is multifactorial, the effect 
endoluminal grafting will have on paraplegia rates is 
unknown. Although the opportunity for intercostal 
reimplantation is not possible, there is less ischemic 
time and it is hoped that the incidence of paraplegia 
will be no worse than that associated with the open 
repair. 
Operative mortality for this small series of select 
patients was 7% (n = 3). Multiple authors have 
reported mortality rates ranging from 2% to 15%, 
although most included emergency as well as elec- 
tive procedures. Fully 50% of our patients were not 
considered to be operative candidates, however, so 
this mortality rate may not be excessively high. 
Stent-graft sizing was determined from a preop- 
erative spiral computed tomographic scan. Stent- 
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graft diameter was always oversized by i to 3 mm to 
achieve a tight friction seal, theoretically allowing 
continued stent-graft radial expansion should aortic 
dilatation in either "neck" region progress in the 
future. 
Occlusive aortoiliac disease is a relative contrain- 
dication for femoral access, although some have 
proposed balloon angioplasty to a size sufficient o 
pass the 26F sheath. Planned femoral access failed 
in five patients, two female and three male. A 
retroperitoneal approach to the iliac artery or aorta 
was successful in four of these patients, but one 
patient had disruption of an aortoiliac graft that 
required emergency repair, probably contributing to 
that patient's early operative death. Some anatomic 
situations were obviously more favorable than oth- 
ers. Placement of a thoracic stent-graft concomi- 
tantly with retroperitoneal bdominal aortic aneu- 
rysm repair, through a 10 mm side arm, was 
generally simple and quick. Lesions in the relatively 
straighter middescending thoracic aorta were gener- 
ally more amenable to stent-graft repair than were 
lesions in the distal arch or lesions associated with a 
serpentine course of the aorta through the dia- 
phragm. Penetrating ulcers or saccular aneurysms 
were also generally more easily repaired than large 
fusiform aneurysms associated with tortuous aortas. 
We currently believe that chronic aortic dissections 
are generally not approachable b cause the cylindri- 
cal graft would not be expected to effect a seal in the 
nonoval true lumen. In the acute type B aortic 
dissection, however, stent-graft coverage of the 
proximal entry point may be possible, with subse- 
quent hrombosis of the false lumen as suggested by 
previous experiments in a canine model, l° We have 
also enjoyed some limited experience with acute 
traumatic aortic disruption at the isthmus. Further 
experience and follow-up will clarify the utility of 
this application. Finally, we have used this approach 
for the second stage of an elephant trunk repair for 
diffuse aneurysmal involvement of the entire tho- 
racic aorta, allowing completion of this procedure in 
a much shorter time course. 
Conclusion 
Further investigation and follow-up are clearly 
necessary to validate this approach for aneurysmal 
repair. Long-term evaluation is mandatory to ascer- 
tain the efficacy of these stent-grafts in preventing 
further aneurysmal dilatation and rupture. Graft 
stability and durability in the long term are also 
essential prerequisites before widespread use is en- 
tertained. In its present state, graft deployment is
inexact and relatively uncontrolled. Improved meth- 
ods of accurate graft placement, miniaturization, 
and capabilities for graft recovery must be devel- 
oped before this technique can be widely applied. 
For patients with adequate ileofemoral access, rel- 
atively straight aortic segments, and no critical arte- 
rial branches, this technology may offer an accept- 
able method for repair of aneurysms of the 
descending thoracic aorta. Whether the perceived 
advantages of reduced operative time, blood loss, 
hospital stay, overall complications, and mortality 
will be confirmed awaits further study. Indeed, 
long-term studies of large numbers of patients over 
decades are necessary to determine the ultimate 
utility of transluminally placed endovascular stent- 
grafts. 
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Discussion 
Dr. Richard P. Anderson (Seattle, Wash.). This is a new 
field for most of us, and if any people in this room have 
had direct experience with stent-grafting of abdominal 
aortic aneurysms, I hope they will comment from 
firsthand knowledge, which I lack. These developments, 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 5 
Mitchell et al. 1 0 6 1 
for the most part, have appeared in the vascular 
literature, not in the cardiovascular literature. 
Charles Dotterer of the University of Oregon, whom 
many of you knew, was an extremely innovative inter- 
ventional radiologist and was probably the first to 
successfully implant experimentally a metallic stent into 
an animal's artery and get long-term patency. This was 
reported in 1969. In the 20 years thereafter, the idea 
that endovascular stenting might be useful in variety of 
applications was widely recognized, and several patents 
have been issued by the U.S. patent office, 
Stents come in various configurations. There is the 
self-expanding stent, such as Dr. Mitchell has described 
here, which is similar to the stent used in biliary tract 
operations. There are also malleable stents that require 
expansion of a balloon catheter witiiin them for deploy- 
ment. Those of us who do cardiac operations are 
familiar with the coronary artery stents that are now so 
prevalent. Cardiologists tend to use them for sealing 
dissections or intimal flaps that have been created 
during angiop!asty. 
The concept of joining a metallic stent to a vascular 
prosthesis for aneurysmal repair was first applied clin- 
ically in the abdominal aorta, and during the last 4 years 
or so there have been several reports in the vascular 
l iterature of trials involving small numbers of patients. 
This technique has been employed with about the same 
degree of success and with the same kind of problems 
that we have heard described here. This is the first 
clinical report of which I am aware, however, of the use 
of an endovascular stent to repair thoracic aneurysms. 
It is also probably the largest single reported series of 
patients with endovascular stent-grafting. The results 
sound promising--7% mortality associated with tho- 
racic aortic aneurysm--particularly when you consider 
the risk factors in the group Dr. Mitchell has shown us, 
half of whom were very high-risk patients. Ninety 
percent aneurysmal thrombosis hortly after stent de- 
ployment is good because you must have aneurysmal 
thrombosis for long-term success. If you do not, and the 
interior of the aneurysm is still subjected to arterial 
pressure, the aneurysm may expand and ultimately 
rupture, as it did late in one of these patients. 
With that as a background, I have a couple of 
question s. First, because leakage around the stent is a 
problem that may lead to either failure of thrombosis or 
late reentry of the circulation into the aneurysmal sac, 
how difficult is it to achieve a complete seal around this 
stent? If you cannot achieve this at the time of deploy- 
ment, what, other options do you have? Or do you 
accept inability to seal a leak at initial deployment? 
Dr. Mitchell. This has been an evolutionary series, 
and we have learned a lot. We think that it is imperative 
to get a complete seal so that there is no filling of the 
aneurysmal sac. At least one of our late deaths was 
certainly instructive, insofar as the necessity of elimi- 
nating aneurysmal opacification is concerned. This pa- 
tient's leak was just distal to the distal stent. I think one 
of the limitations of this technology is that it is impos- 
sible to assess the exact extent of the aneurysm as 
carefully as during Operation. As you saw, however, 29 
patients had exclusion of their aneurysm with a single 
stent, fully another 13 required only two stents, and 
only two patients required three stents. There have 
been some leaks even after that. One patient has 
required interventional coiling of a proximal leak. 
In fact, just before our departure for this meeting, our 
yery first patient, who has been foll6wed up now for 
almost 3 years; acquired a new small leak proximally. 
He is going to undergo coil placement when we get 
back. 
Dr. Anderson. With respect to that case, I recall that the 
early patients in the series were those not at high risk. 
They were patients who would have otherwise been 
operative candidates. Is that correct? 
Dr. Mitchell. That is correct. The first four or five 
patients were all operative candidates. 
Dr. Anderson. At this point, how are you going to 
manage this patient's condition? Are you going to declare 
defeat and go in and operate and resect his aneurysm, or 
are you going to attempt another endovascular proce- 
dure? 
Dr. Mitchell. This patient is pretty insistent, despite 
being pretty healthy, about avoiding an operation. We are 
therefore going to attempt o put coils in when we get 
back to Stanford. 
Dr. Anderson. Tell him that an operation will be a lot 
more pleasant if his aneurysm is not ruptured when it is 
performed. 
I note that you mentioned that you were very careful 
to protect these patients during the initial part of the 
study by various means--procedures were done in the 
operating room with general anesthesia, pump standby, 
operating team, and so on. Yet you have now told us 
that there was no acute need to convert any of these 
procedures to open operation. Have you backed off on 
your precautions, and would you perform procedures in 
the radiology suite now? 
Dr. Mitchell. No. We are not going back off on those 
criteria. The one patient who had paraplegia could have 
had some significant amelioration of these complica- 
tions had distal bypass been instituted instantly, and so 
I think we will continue to have cardiopulmonary 
bypass available and have surgeons tanding by in the 
operating room. 
Dr. Anderson. Would you comment then on the recent 
trial of stent-grafting of abdominal aortic aneurysms? I 
understand that the investigators aborted the trial about 
halfway through. Could you comment on that in light of 
your own experience and discuss whether the same prob- 
lems might not arise in your series? 
Dr. Mitchell. The stent-graft repair to which you are 
referring is with the stent manufactured by Endovascu- 
lar Technologies, Inc. (Menlo Park, Calif.), which is for 
infrarenal aneurysmal repair. That was a stent commer- 
cially manufactured specifically for this graft repair and 
is different in many aspects from the device used in our 
study. The first difference is that they used hooks to 
attach their device to the aortic wall, and one of the 
fracture points happened to be in that radius of curva- 
ture. Subsequently, they have developed a model to test 
it, and they can now duplicate that failure. They think 
there is a fatigue problem at that curvature. That has 
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been modified with an increased radius Of curvature, 
and they have not seen subsequent fractures. The other 
site of fracture was at a weld site of this hook to the 
actual stent, and that has been eliminated in the 
subsequent design iterations of this device. The modi- 
fied device is currently back in consideration at the 
Food and Drug Administration, and clinical trials are 
scheduled to resume in early November of 1995. 
Dr. Anderson. I Commend you not only on the results 
that you have achieved but on your courage in attempting 
this very innovative technique. I am certain that it will 
have application i  selected patients in the future. 
